Uppsala, Sweden

Gunnar Tufveson

This inventor holds 1 USPTO granted patent. Top assignee: Linc Invest Ab. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gunnar Tufveson. Retrieved from https://idiyas.com/inventor/gunnar-tufveson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Gunnar Tufveson

Introduction

Gunnar Tufveson is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of medicine, particularly in the treatment of inflammation. His innovative approach has led to the development of a unique patent that addresses a critical health issue.

Latest Patents

Gunnar Tufveson holds a patent for the "Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation." This patent focuses on the application of hyaluronidase in treating inflammation associated with increased local synthesis of hyaluronan in mammals. The method involves administering hyaluronidase either locally or systemically, which effectively reduces inflammatory cell infiltration.

Career Highlights

Throughout his career, Tufveson has been associated with Linc Invest AB, where he has been able to apply his expertise in the pharmaceutical field. His work has been instrumental in advancing treatments that improve patient outcomes in inflammatory conditions.

Collaborations

Gunnar Tufveson has collaborated with notable colleagues, including Cecilia Johnsson and Roger Hällgren. These partnerships have fostered a productive environment for innovation and research.

Conclusion

Gunnar Tufveson's contributions to the field of medicine through his patent on hyaluronidase exemplify the impact of innovative thinking in healthcare. His work continues to influence the development of effective treatments for inflammation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…